08/14/2025
7:48 AM | Deep Track Capital, LP (Filed by)
MBX Biosciences (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
9:34 AM | MBX Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
08/07/2025
7:46 AM | MBX Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2025
7:10 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
7:02 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:59 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
10:29 AM | Mathers Edward T (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:59 AM | Hoerter Steven L. (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:03 AM | MBX Biosciences (Issuer)
Ryder Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:04 AM | CORNELIUS JAMES M (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:05 AM | Aynechi Tiba (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MBX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MBX Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
6:59 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
7:01 AM | MBX Biosciences (Issuer)
Pescovitz Ora H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:02 AM | Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
9:44 AM | MBX Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
7:11 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
7:19 AM | MBX Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
7:43 AM | MBX Biosciences (Filer)
| Form DEF 14A | |
04/23/2025
7:45 AM | MBX Biosciences (Filer)
| Form DEFA14A | |
04/23/2025
7:46 AM | MBX Biosciences (Filer)
| Form ARS | |
04/10/2025
7:39 AM | MBX Biosciences (Issuer)
Pescovitz Ora H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
7:27 AM | Hoerter Steven L. (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
7:24 AM | Hoerter Steven L. (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/07/2025
7:11 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
7:34 AM | MBX Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/17/2025
7:07 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
7:14 AM | MBX Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
4:52 PM | MBX Biosciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
4:56 PM | GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:17 PM | Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:17 PM | Bartram Richard (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:17 PM | Azoulay Salomon (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
6:21 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | MBX Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
7:31 AM | MBX Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:08 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:38 PM | Hawryluk P. Kent (Filed by)
MBX Biosciences (Subject)
| Form SC 13G | |
09/23/2024
5:05 PM | MBX Biosciences (Subject)
New Enterprise Associates 17, L.P. (Filed by)
| Form SC 13D | |
09/23/2024
5:07 PM | MBX Biosciences (Subject)
Norwest Venture Partners XVI, LP (Filed by)
| Form SC 13D | |
09/23/2024
3:34 PM | MBX Biosciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D | |
09/23/2024
9:48 AM | Frazier Life Sciences Public Fund, L.P. (Filed by)
MBX Biosciences (Subject)
| Form SC 13D | |
GENIUS Act: Cancel Your Money? (Ad) A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control.
Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live. Get the free info kit with 3 strategies to sidestep digital dollar control. |
09/20/2024
9:13 AM | MBX Biosciences (Subject)
Wellington Biomedical Innovation Master Investors II L.P. (0001903360) (Filed by)
| Form SC 13G | |
09/17/2024
7:20 PM | Makhzoumi Mohamad (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:21 PM | Florence Anthony A. Jr. (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:23 PM | Chang Carmen (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:24 PM | Behbahani Ali (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:26 PM | BASKETT FOREST (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:28 PM | Mathers Edward T (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:07 PM | Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:09 PM | Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:11 PM | CORNELIUS JAMES M (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:11 PM | FHMLS X, L.L.C. (Reporting)
FHMLS X, L.P. (Reporting)
Frazier Life Sciences X, L.P. (Reporting)
MBX Biosciences (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:12 PM | MBX Biosciences (Issuer)
NEA 17 GP, LLC (Reporting)
NEA Partners 17, L.P. (Reporting)
New Enterprise Associates 17, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:13 PM | MBX Biosciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:14 PM | MBX Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:17 PM | MBX Biosciences (Issuer)
Yang Rick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:18 PM | MBX Biosciences (Issuer)
Walker Paul Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:05 PM | GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
7:05 PM | Aynechi Tiba (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:15 PM | MBX Biosciences (Issuer)
Wellington Biomedical Innovation Master Investors II L.P. (0001903360) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:21 PM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
4:17 PM | MBX Biosciences (Issuer)
Ryder Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:19 PM | GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:00 PM | MBX Biosciences (Issuer)
Pescovitz Ora H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:02 PM | CORNELIUS JAMES M (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:04 PM | Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:04 PM | Aynechi Tiba (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:06 PM | Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:11 PM | Mathers Edward T (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:11 PM | Azoulay Salomon (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:13 PM | Bartram Richard (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:26 PM | MBX Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/12/2024
11:15 PM | MBX Biosciences (Filer)
| Form EFFECT | |
09/12/2024
6:52 PM | MBX Biosciences (Issuer)
Wellington Biomedical Innovation Master Investors II L.P. (0001903360) (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:36 PM | MBX Biosciences (Issuer)
Walker Paul Edward (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:38 PM | MBX Biosciences (Issuer)
Yang Rick (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:15 PM | FHMLS X, L.L.C. (Reporting)
FHMLS X, L.P. (Reporting)
Frazier Life Sciences X, L.P. (Reporting)
MBX Biosciences (Issuer)
Topper James N (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:15 PM | GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:17 PM | MBX Biosciences (Issuer)
Ryder Steven (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:17 PM | Aynechi Tiba (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:19 PM | MBX Biosciences (Issuer)
Pescovitz Ora H. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:19 PM | MBX Biosciences (Issuer)
NEA 17 GP, LLC (Reporting)
NEA Partners 17, L.P. (Reporting)
New Enterprise Associates 17, L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:20 PM | Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:22 PM | BASKETT FOREST (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:23 PM | CORNELIUS JAMES M (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:24 PM | Behbahani Ali (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:26 PM | Chang Carmen (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:27 PM | Florence Anthony A. Jr. (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:29 PM | Makhzoumi Mohamad (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:31 PM | Mathers Edward T (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:33 PM | MBX Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
These 5 Stocks Are Thriving Under Trump’s Presidency (Ad) Trump is back in the White House—and new market winners are already emerging.
A free report reveals 5 stocks poised to benefit from early policy shifts, sector momentum, and the evolving 2025 economy. Download your free report: 5 Best Stocks for Trump’s America |
09/12/2024
6:34 PM | Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:09 PM | Bartram Richard (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:10 PM | Azoulay Salomon (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:14 PM | MBX Biosciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
5:05 PM | MBX Biosciences (Filer)
| Form S-1MEF | |
09/12/2024
11:11 AM | MBX Biosciences (Filer)
| Form CERT | |
09/10/2024
3:28 PM | MBX Biosciences (Filer)
| Form 8-A12B | |
09/09/2024
5:06 AM | MBX Biosciences (Filer)
| Form S-1/A | |
08/30/2024
4:13 PM | MBX Biosciences (Filer)
| Form S-1/A | |
MarketBeat All Access